PMC:7558233 / 32678-32913 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"821","span":{"begin":89,"end":126},"obj":"Gene"},{"id":"824","span":{"begin":83,"end":88},"obj":"Species"},{"id":"825","span":{"begin":191,"end":199},"obj":"Species"},{"id":"832","span":{"begin":128,"end":135},"obj":"Disease"},{"id":"833","span":{"begin":205,"end":213},"obj":"Disease"},{"id":"834","span":{"begin":223,"end":234},"obj":"Disease"}],"attributes":[{"id":"A821","pred":"tao:has_database_id","subj":"821","obj":"Gene:1440"},{"id":"A824","pred":"tao:has_database_id","subj":"824","obj":"Tax:9606"},{"id":"A825","pred":"tao:has_database_id","subj":"825","obj":"Tax:9606"},{"id":"A832","pred":"tao:has_database_id","subj":"832","obj":"MESH:D002559"},{"id":"A833","pred":"tao:has_database_id","subj":"833","obj":"MESH:C000657245"},{"id":"A834","pred":"tao:has_database_id","subj":"834","obj":"MESH:D008231"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Mobilizing the trafficking of lymphocytes to the peripheral blood with recombinant human granulocyte colony stimulating factor (rhG-CSF) might represent an appealing therapeutic approach for patients with COVID-19 who have lymphopenia."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T55","span":{"begin":223,"end":234},"obj":"Phenotype"}],"attributes":[{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0001888"}],"text":"Mobilizing the trafficking of lymphocytes to the peripheral blood with recombinant human granulocyte colony stimulating factor (rhG-CSF) might represent an appealing therapeutic approach for patients with COVID-19 who have lymphopenia."}

{"project":"LitCovid-sentences","denotations":[{"id":"T196","span":{"begin":0,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Mobilizing the trafficking of lymphocytes to the peripheral blood with recombinant human granulocyte colony stimulating factor (rhG-CSF) might represent an appealing therapeutic approach for patients with COVID-19 who have lymphopenia."}